|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000016782 |
| Receipt No. | R000019475 |
| Scientific Title | An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancer |
| Date of disclosure of the study information | 2015/03/23 |
| Last modified on | 2020/05/21 17:02:40 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2015/03/11 18:58:19 | ||
| 2 | Update | 2015/03/24 10:22:51 | Last name of contact person Last name of contact person Division name Address Name of person sending information Name of person sending information |
|
| 3 | Update | 2015/03/24 10:24:27 | Email |
|
| 4 | Update | 2015/06/16 12:10:19 | Recruitment status |
|
| 5 | Update | 2015/10/15 19:17:36 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
| 6 | Update | 2016/09/12 09:04:56 | Name of primary sponsor Organization |
|
| 7 | Update | 2017/06/14 19:06:42 | Recruitment status |
|
| 8 | Update | 2020/03/13 14:05:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Zip code Organization1 Address1 Tel1 Organization Organization Address Address Tel |
|
| 9 | Update | 2020/05/21 17:02:40 | Date of IRB Last follow-up date |
